Clinical Trial Update: To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Trexima for the acute treatment of migraine has completed, assessing its safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Trexima (sumatriptan/naproxen)

Snippet

Sponsor: POZEN | Conditions: Migraine Headaches | Phase 3 | Status: COMPLETED